Revvity · 2 weeks ago
Quality Control Associate I, Flow Cytometry (PM Shift)
Revvity is dedicated to developing world-class antibodies and reagents for biomedical research, manufactured in their state-of-the-art facility in San Diego, CA. The Quality Control Associate will test products in various applications, perform aseptic cell culture, and maintain laboratory equipment while ensuring compliance with SOPs and ISO requirements.
Health CareLife Science
Responsibilities
Perform testing of reagents in a timely manner
Perform aseptic cell culture
Isolate primary cells and tissues
Perform data analysis and document results
Maintain a safe and clean laboratory
Other projects or responsibilities as may be required
Qualification
Required
High School Diploma (or equivalent)
6 months+ experience with some of the following applications: flow cytometry, western blotting, Immunoprecipitation, bioassays, ELISA and IHC/ICC is a big plus
>1 year working experience in a laboratory environment
Preferred
Bachelor's degree in a scientific discipline
Experience in sterile cell culture technique
Familiarity with basic lab equipment and knowledge of lab safety protocols
Excellent organization, communication, and problem-solving skills
Proven ability to multi-task
Excellent documentation skills
Benefits
Medical, Dental, and Vision Insurance Options
Life and Disability Insurance
Paid Time-Off
Parental Benefits
Compassionate Care Leave
401k with Company Match
Employee Stock Purchase Plan
Company
Revvity
Accelerating science. Transforming health. Expanding human potential. This is Revvity.
H1B Sponsorship
Revvity has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.5B2025-01-07Post Ipo Debt· $1.5B
2023-05-16IPO
Leadership Team
Recent News
2025-12-24
Research & Development World
2025-12-19
Company data provided by crunchbase